Previous close | 0.0002 |
Open | 0.0002 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0002 - 0.0002 |
52-week range | 0.0001 - 0.1000 |
Volume | |
Avg. volume | 14,159,435 |
Market cap | 20,472 |
Beta (5Y monthly) | 0.69 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Item 9 Labs Corp. (OTCPK: INLB) ("INLB" or the "Company"), a vertically integrated cannabis operator and dispensary franchisor that produces high-grade, award-winning products has retained Sharp Capital Advisors LLC ("Sharp") to assist in the exploration of a sale of the Company. The Company consists of two core operating businesses, Item 9 Labs and Unity Rd.
PHOENIX, May 23, 2023--INLB Corp. has executed a major restructuring to right-size its operations and cost structure while working toward a return to profitability.
PHOENIX, May 10, 2023--After a successful test run in December, Item 9 Labs released its limited edition one-gram rosin-infused pre-rolls in participating AZ dispensaries.